Evidence map›Paper›PMID 34716158›Full record

ArticleBMJ open2021

Is improvement in indicators of women's empowerment associated with uptake of WHO recommended IPTp-SP levels in sub-Saharan Africa? A multilevel approach.

Edward Kwabena Ameyaw, Carolyne Njue, Roberta Mensima Amoah, Francis Appiah, Linus Baatiema, Bright Opoku Ahinkorah, Abdul-Aziz Seidu, John Kuumuori Ganle, Sanni Yaya

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BMJ open, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Edward Kwabena AmeyawFaculty of Health, The Australian Centre for Public and Population Health Research, University of Technology Sydney, Sydney, New South Wales, Australia.
Carolyne NjuePublic Health, University of Technology Sydney, Sydney, New South Wales, Australia.ORCID 0000-0001-9325-3565
Roberta Mensima AmoahDepartment of Public Health, University for Development Studies, Tamale, Ghana.
Francis AppiahDepartment of Social Sciences, Berekum College of Education, Berekum, Ghana.
Linus BaatiemaDepartment of Population and Health, Faculty of Social Sciences, University of Cape Coast, Cape Coast, Central, Ghana.
Bright Opoku AhinkorahFaculty of Health, The Australian Centre for Public and Population Health Research, University of Technology Sydney, Sydney, New South Wales, Australia.ORCID 0000-0001-7415-895X
Abdul-Aziz SeiduDepartment of Population and Health, Faculty of Social Sciences, University of Cape Coast, Cape Coast, Central, Ghana.ORCID 0000-0001-9734-9054
John Kuumuori GanleDepartment of Population, Family and Reproductive Health, University of Ghana, Legon, Ghana.
Sanni YayaSchool of International Development and Global Studies, University of Ottawa, Ottawa, Ontario, Canada sanni.yaya@uOttawa.ca.ORCID 0000-0002-4876-6043

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThe global burden of malaria has reduced considerably; however, malaria in pregnancy remains a major public health problem in sub-Saharan Africa (SSA), where about 32 million pregnant women are at risk of acquiring malaria. The WHO has recommended that pregnant women in high malaria transmission locations, including SSA, have intermittent preventive treatment of malaria during pregnancy with at least three doses of sulphadoxine-pyrimethamine (IPTp-SP). Therefore, we investigated the prevalence of IPTp-SP uptake and associated individual-level, community-level and country-level predictors in SSA.

designA cross-sectional survey was conducted using recent Demographic and Health Surveys datasets of 20 SSA countries. A total of 96 765 women were included. Optimum uptake of IPTp-SP at most recent pregnancy was the outcome variable. We fitted three-level multilevel models: individual, community and country parameters at 95% credible interval.

resultsIn all, 29.2% of the women had optimal IPTp-SP uptake ranging from 55.1% (in Zambia) to 6.9% (in Gambia). The study revealed a high likelihood of optimum IPTp-SP uptake among women with high knowledge (aOR=1.298, Crl 1.206 to 1.398) relative to women with low knowledge. Women in upper-middle-income countries were more than three times likely to have at least three IPTp-SP doses compared with those in low-income countries (aOR=3.268, Crl 2.392 to 4.098). We found that community (σ

conclusionsThe outcome of our study suggests that low-income SSA countries should increase budgetary allocation to maternal health, particularly for IPTp-SP interventions. IPTp-SP advocacy behavioural change communication strategies must focus on women with low knowledge, rural dwellers, married women and those who do not meet the minimum of eight antenatal care visits.

Indexed as

AntimalarialsMalariaPregnancy Complications, ParasiticPrenatal CareAfrica South of the SaharaCross-Sectional StudiesDrug CombinationsEmpowermentFemaleHumansPregnancyWorld Health OrganizationAntimalarialsDrug Combinationscommunity child healthepidemiologyhealth policyprimary care

Identifiers

PMID34716158
PMCPMC8559097

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.